During the past decade, St.Johann Nepomuk Katholisches Hospitalvereinigung Thüringen GmbH conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St.Johann Nepomuk Katholisches Hospitalvereinigung Thüringen GmbH" are "Atrial Fibrillation" (2 trials), "Stroke" (2 trials) and "Bleeding" (1 trials). Many other conditions were trialed in "St.Johann Nepomuk Katholisches Hospitalvereinigung Thüringen GmbH" in a lesser frequency.

Most popular intervention types in "St.Johann Nepomuk Katholisches Hospitalvereinigung Thüringen GmbH" are "Device" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Market-approved OAC" (1 trials), "Non-Vitamin K Oral Anticoagulant" (1 trials), "Single Antiplatelet Therapy or No Therapy (Control)" (1 trials), "WATCHMAN FLX Implant" (1 trials) and "WATCHMAN FLX LAAC Device" (1 trials). Other intervention names were less common.

The vast majority of trials in "St.Johann Nepomuk Katholisches Hospitalvereinigung Thüringen GmbH" are 3 trials for "All" genders.

Currently, there are NaN active trials in "St.Johann Nepomuk Katholisches Hospitalvereinigung Thüringen GmbH". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in St.Johann Nepomuk Katholisches Hospitalvereinigung Thüringen GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St.Johann Nepomuk Katholisches Hospitalvereinigung Thüringen GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".